<ѻýҕl>No Early Cardiovascular Risks With Testosterone Treatmentѻýҕl> Data on long-term safety needed, however Jun 13, 2022
<ѻýҕl>P53 Antagonist Shows Early Activity in Advanced Liposarcomaѻýҕl> ASCO roundup: ADC targeting CD46 slows mCRPC, molecule stabilizes effects of "hot spot" mutation Jun 08, 2022
<ѻýҕl>She Found Out She Had Prostate Cancerѻýҕl> Then Eve Gammill, a transgender woman, fully embraced her feminine identity Jun 07, 2022
<ѻýҕl>Just How Effective Is PSA Screening?ѻýҕl> Study finds test has better benefit/harm trade-off than originally thought May 18, 2022
<ѻýҕl>Mental Health Issues Common, Often Overlooked in Prostate Cancerѻýҕl> More than a third of patients with anxiety, depression, fear of recurrence/disease progression May 17, 2022
<ѻýҕl>Drastic Drop in Antibiotic Overuse for Common Urology Procedure: How They Did Itѻýҕl> Single center's strategy cut antibiotic administration by 30% in cystoscopy May 16, 2022
<ѻýҕl>Urologists Are Helping Combat the Opioid Epidemic, Studies Suggestѻýҕl> Three reports show success in reducing opioid prescribing May 16, 2022
<ѻýҕl>Gene Therapy for Overactive Bladder Shows Early Promiseѻýҕl> Significant improvements in symptoms, quality of life after short-term follow-up May 16, 2022
<ѻýҕl>Robotic Surgery Wins for Keeping Bladder Cancer Patients Alive, Out of Hospitalѻýҕl> Approach bested open surgery in iROC trial, but is the difference clinically important? May 15, 2022
<ѻýҕl>Food Insecurity Linked With Urge Urinary Incontinenceѻýҕl> Suggests social factors play a role, independent of dietary bladder irritants May 15, 2022
<ѻýҕl>Combo Treatment Scores Big in BCG-Unresponsive Bladder Cancerѻýҕl> Significantly durable response with VesAnktiva-Bacillus Calmette-Guérin duo May 15, 2022
<ѻýҕl>Good Vibrations: The Transition From Sex Toy to Medical Deviceѻýҕl> Benefits of vibrators in urinary incontinence, vulvodynia, sexual dysfunction in women May 14, 2022
<ѻýҕl>Vaginal Estrogen 'Underutilized' in Women With GSM After Breast Cancerѻýҕl> Prescribing rate is half that of women with no breast cancer history May 13, 2022
<ѻýҕl>Urinary Symptoms Linked to Increased Mortality Risk in Menѻýҕl> Moderate to severe symptoms "good indicators" of poor health, study authors say May 06, 2022
<ѻýҕl>End of the Line for a Failed Prostate Cancer Drugѻýҕl> Orteronel misses mark in metastatic hormone-sensitive prostate cancer, after failures in mCRPC Apr 29, 2022
<ѻýҕl>Another Robotic Approach for Bladder Cancer Removal Proves Its Mettleѻýҕl> Robot-assisted laparoscopy with ICUD tied to better survival versus open surgery Apr 29, 2022
<ѻýҕl>Another Link Between Prostate Cancer Hormone Tx and Impaired Cognitionѻýҕl> Strongest association with enzalutamide, but survival benefit outweighs effect, specialists say Apr 25, 2022
<ѻýҕl>Testicular Mass Serendipitously Found 12 Years After Prostate Cancer Dxѻýҕl> Consistently low PSA levels failed to signal metastasis Apr 18, 2022
<ѻýҕl>Genetic Score Shows Promise for Honing PSA Precisionѻýҕl> Fewer unnecessary biopsies projected with use of genetics-adjusted values Apr 12, 2022
<ѻýҕl>ED Meds Linked to Higher Risk of Ocular Adverse Eventsѻýҕl> Adjusted incidence rate ratio of 1.85 for three serious conditions with use of PDE5 inhibitors Apr 07, 2022
<ѻýҕl>$150K Prostate Cancer Drug Draws New Attention to 'March-In' Rightsѻýҕl> Advocates want Biden administration to enable Xtandi generics; industry warns against it Apr 06, 2022
<ѻýҕl>Mini-Sling Matches Midurethral Sling for Urinary Incontinence in Womenѻýҕl> While both procedures led to success, cure remained elusive Mar 30, 2022
<ѻýҕl>Another Oral Testosterone Undecanoate OK'd for Hypogonadismѻýҕl> FDA approval of Tlando follows in the footsteps of Jatenzo Mar 29, 2022
<ѻýҕl>Digital Device Proves Effective for Treating Urinary Incontinence in Womenѻýҕl> Pelvic floor muscle training using motion-based device led to improvements in symptom severity Mar 14, 2022
<ѻýҕl>COVID in Your Junk? The Idea Isn't Bunk, Study Suggestsѻýҕl> New research in monkeys finds virus lurks in the male reproductive system Mar 08, 2022
<ѻýҕl>Check Troponin in RCC Patients Before Checkpoint-VEGFR Inhibitor Comboѻýҕl> In JAVELIN Renal 101, those with high levels had more heart events with avelumab-axitinib Mar 05, 2022
<ѻýҕl>Cancer May Heighten Odds of Guillain-Barre Syndromeѻýҕl> Link strongest with hematologic malignancies as well as prostate, breast, and respiratory cancers Mar 03, 2022
<ѻýҕl>Enzalutamide Rechallenge Yields Small PFS Boost in Metastatic Prostate Cancerѻýҕl> Docetaxel-enzalutamide regimen may offer another option for men who progressed on AR inhibitor Feb 18, 2022
<ѻýҕl>Two PARP Inhibitors Impress as First-Line Add-Ons in mCRPCѻýҕl> In one case, rPFS benefit was seen regardless of HRR mutational status Feb 18, 2022
<ѻýҕl>Darolutamide Improves OS in Metastatic Prostate Cancerѻýҕl> The AR inhibitor plus standard therapy led to a 32% reduced risk of death versus placebo Feb 17, 2022
<ѻýҕl>Here's How Ob/Gyns Can Create Gender-Affirming Environmentsѻýҕl> Focusing on social and emotional needs goes a long way, experts say Feb 10, 2022
<ѻýҕl>Active Cellular Immunotherapy Disappoints in Metastatic Prostate Cancerѻýҕl> In combination with chemotherapy, no OS benefit seen with DCVAC/PCa over placebo Feb 10, 2022
<ѻýҕl>We've Never Really Understood the Prostateѻýҕl> Wolinsky reviews Ericka Johnson's new book, A Cultural Biography of the Prostate Jan 19, 2022
<ѻýҕl>In Early Prostate Cancer, Black Men Do Better With Radiotherapy Than White Menѻýҕl> "Unexpected" finding holds even though Black men are more likely to have high-risk features Dec 29, 2021
<ѻýҕl>Let's Break the Incontinence Tabooѻýҕl> Too few of our patients know that treatment is an option Dec 19, 2021
<ѻýҕl>NCCN Reverses on Guideline Change for Surveillance in Prostate Cancerѻýҕl> Active surveillance again preferred choice for "most" men with low-risk disease Dec 01, 2021
<ѻýҕl>FDA OKs PD-1 Inhibitor for Adjuvant Treatment of Kidney Cancerѻýҕl> Key trial showed 32% reduction in risk of recurrence with pembrolizumab Nov 18, 2021
<ѻýҕl>Mixed Results With RT Plus Short-Term ADT in Intermediate-Risk Prostate Cancerѻýҕl> No survival benefit, but risk of biochemical failure, metastasis, cancer death improved Oct 28, 2021
<ѻýҕl>Meta-Analysis Reaffirms Role of ADT With Radiotherapy in Prostate Cancerѻýҕl> Prolonged adjuvant ADT also improved survival Oct 27, 2021